1st Quarter - Report
KING & SPALDING LLP for SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.)
Firm
Income
$40,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to inclusion of prescription drugs within Essential Health Benefit; H.R. 2646, Helping Families in Mental Health Crisis Act of 2015; S. 1945, Mental Health Reform Act of 2015; S. 2680, Mental Health Reform Act of 2016; and mental health coverage expansion
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL F DONOVAN | Senate Committees on Finance, Small Business, and Government Affairs |
| DAVID JOSEPH FARBER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.